{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:54:37Z","timestamp":1791222877416,"version":"4.1.0"},"reference-count":11,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.3201\/eid2202.151238","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T15:57:17Z","timestamp":1448467037000},"page":"210-2106","source":"Crossref","is-referenced-by-count":24,"title":["Feasibility of Xpert Ebola Assay in M\u00e9decins Sans Fronti\u00e8res Ebola Program, Guinea"],"prefix":"10.3201","volume":"22","author":[{"given":"Rafael","family":"Van den Bergh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Chaillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamadou Saliou","family":"Sow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Amand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"van Vyve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Jonckheere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Crestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Sprecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Van Herp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Piriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamine","family":"Koivogui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Antierens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2202.151238-201601131122-R1","unstructured":"World Health Organization. Ebola situation report\u2014June 28, 2015. Geneva: The Organization; 2015."},{"key":"key-10.3201\/eid2202.151238-201601131122-R2","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1056\/NEJMoa1411680","article-title":"Clinical illness and outcomes in patients with Ebola in Sierra Leone.","volume":"371","author":"Schieffelin","year":"2014","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2202.151238-201601131122-R3","unstructured":"World Health Organization. Policy statement. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB\/RIF system. Geneva: The Organization; 2011."},{"key":"key-10.3201\/eid2202.151238-201601131122-R4","unstructured":"Hamburg MA. Authorization of the emergency use of the Xpert Ebola Assay, US Food and Drug Administration; 2015 [cited 2015 Nov 10]. http:\/\/www.fda.gov\/downloads\/MedicalDevices\/Safety\/EmergencySituations\/UCM439583.pdf"},{"key":"key-10.3201\/eid2202.151238-201601131122-R5","unstructured":"World Health Organization. WHO emergency use assessment and listing for EVD IVDs: Xpert Ebola Assay. Geneva: The Organization; 2015."},{"key":"key-10.3201\/eid2202.151238-201601131122-R6","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0140-6736(14)62043-2","article-title":"First trials for Ebola treatments announced.","volume":"384","author":"Mohammadi","year":"2014","journal-title":"Lancet"},{"key":"key-10.3201\/eid2202.151238-201601131122-R7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1056\/NEJMoa1411249","article-title":"Clinical presentation of patients with Ebola virus disease in Conakry, Guinea.","volume":"372","author":"Bah","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2202.151238-201601131122-R8","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0140-6736(15)61042-X","article-title":"ReEBOV antigen rapid test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study.","volume":"386","author":"Broadhurst","year":"2015","journal-title":"Lancet"},{"key":"key-10.3201\/eid2202.151238-201601131122-R9","doi-asserted-by":"publisher","first-page":"21073","DOI":"10.2807\/1560-7917.ES2015.20.12.21073","article-title":"Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, western area, Sierra Leone, January to February 2015.","volume":"20","author":"Walker","year":"2015","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid2202.151238-201601131122-R10","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0140-6736(13)62073-5","article-title":"Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB\/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial.","volume":"383","author":"Theron","year":"2014","journal-title":"Lancet"},{"key":"key-10.3201\/eid2202.151238-201601131122-R11","doi-asserted-by":"publisher","first-page":"e89301","DOI":"10.1371\/journal.pone.0089301","article-title":"Feasibility of decentralised deployment of Xpert MTB\/RIF test at lower level of health system in India.","volume":"9","author":"Raizada","year":"2014","journal-title":"PLoS ONE"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/22\/2\/15-1238_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T23:24:39Z","timestamp":1732922679000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/22\/2\/15-1238_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2202.151238","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}